Clinical Trial: Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers

U.S., Dec. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07304726) titled 'Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers' on Dec. 14.

Brief Summary: This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-383 in healthy volunteers

Study Start Date: Oct. 30

Study Type: INTERVENTIONAL

Condition: Type 2 Diabetes

Intervention: DRUG: CKD-383 0.25/12.5/1000mg

QD, PO

DRUG: CKD-501, D745, D150

QD, PO

Recruitment Status: COMPLETED

Sponsor: Chong Kun Dang Pharmaceutical

Published by HT Digital Content Services with permission from Health Daily Digest....